Skip to content
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Endocrinology

Can I Get Pregnant With a Prolactinoma? Is Medication Safe?

At a Glance

Yes, you can get pregnant with a prolactinoma. Medications like cabergoline and bromocriptine safely restore fertility and are usually stopped once pregnancy is confirmed. Most women with prolactinomas have healthy pregnancies, though larger tumors may require extra monitoring.

Yes, you can absolutely get pregnant if you have a prolactinoma. While a prolactinoma can cause temporary infertility, treatment with dopamine agonist medications (like cabergoline or bromocriptine) is highly effective at restoring your fertility. Furthermore, these medications are generally safe to take while trying to conceive, and most women with prolactinomas go on to have healthy, normal pregnancies.

How a Prolactinoma Affects Fertility

Prolactin is the hormone naturally responsible for breast milk production. When a prolactinoma (a benign tumor of the pituitary gland) produces too much prolactin, it signals to your brain that your body is already pregnant or nursing [1].

High prolactin levels suppress the release of gonadotropin-releasing hormone from the hypothalamus, which in turn drops the levels of LH (luteinizing hormone) and FSH (follicle-stimulating hormone) [2]. Without normal levels of LH and FSH, your ovaries stop releasing eggs (ovulation). This leads to irregular periods or no periods at all (amenorrhea), and temporary infertility [1][3].

Restoring Fertility with Medication

The good news is that infertility caused by a prolactinoma is very treatable. Medications called dopamine agonists—most commonly cabergoline or bromocriptine—mimic the natural dopamine in your brain to lower prolactin levels and shrink the tumor [4].

Once your prolactin levels drop back into the normal range, your brain resumes its normal hormone signaling, and regular ovulation typically returns [5][2]. For many women, fertility is fully restored within a few months of starting medication. If your cycles do not return after several months of normal prolactin levels, your doctor may recommend seeing a fertility specialist to check for other causes.

Are Dopamine Agonists Safe When Trying to Conceive?

Yes. Both bromocriptine and cabergoline have excellent safety profiles when used to achieve pregnancy. Extensive research shows that taking these medications during conception and early pregnancy does not increase the risk of miscarriage, preterm delivery, or birth defects compared to the general population [6][7][8].

While both medications are considered safe, your doctor may have a preference depending on your specific situation:

  • Bromocriptine has been used for decades and has the longest track record of safety data during pregnancy [9][10].
  • Cabergoline is often the preferred choice for treating prolactinomas because it works faster and has fewer side effects, and modern studies continue to confirm it is also highly safe during early pregnancy [11][7].

What Happens to Medication Once You Are Pregnant?

As soon as you have a positive pregnancy test, you should contact your endocrinologist. The standard of care usually involves stopping your dopamine agonist immediately upon confirming pregnancy [11][12].

However, the exact plan depends on the size of your tumor:

If You Have a Microprolactinoma

A microprolactinoma is a tumor smaller than 10 millimeters in diameter. The risk of a microprolactinoma growing enough to cause symptoms during pregnancy is very low [13]. If you have a microprolactinoma, you will almost certainly be advised to stop your medication as soon as you are pregnant [7]. You likely won’t need routine MRI scans during your pregnancy, though your doctor will monitor you for symptoms like new severe headaches or vision changes [7][8].

If You Have a Macroprolactinoma

A macroprolactinoma is a tumor 10 millimeters or larger. During all pregnancies, the pituitary gland naturally swells, which can increase the risk of a larger tumor pressing on the optic nerves (which control vision) [13].

Because of this risk, your care team will tailor a plan specific to your tumor:

  • If your macroprolactinoma is very large or invasive, your doctor might recommend continuing your dopamine agonist throughout your entire pregnancy to prevent the tumor from growing [9][8].
  • Your doctor will likely suggest getting a baseline visual field test (an eye exam to check your peripheral vision) before you start trying to conceive, so they have a comparison point.
  • If you stop the medication, you will be monitored more closely during your pregnancy, often with repeat visual field tests [14][13].
  • If the tumor does begin to grow and cause symptoms (like severe headaches or vision changes), your doctor can simply restart the dopamine agonist. Restarting the medication is highly effective at shrinking the tumor safely during pregnancy [12][15].

Why Your Doctor Won’t Check Your Prolactin Levels During Pregnancy

Patients with prolactinomas are used to getting their prolactin levels checked frequently. However, during pregnancy, doctors usually stop ordering this blood test. This is because prolactin levels naturally skyrocket in all pregnant women to prepare the body for breastfeeding [16][17]. Because the blood test cannot distinguish between normal “pregnancy prolactin” and “tumor prolactin,” checking the levels is not useful and would likely only cause unnecessary anxiety [17].

Postpartum Care and Breastfeeding

Many women with prolactinomas wonder if they will be able to breastfeed. The short answer is yes: breastfeeding is generally considered safe and does not increase the risk of your tumor growing or recurring [18][19].

However, because dopamine agonists work by directly suppressing prolactin, restarting your medication will severely reduce or stop your breast milk production [20][18]. If your tumor was small and stable during pregnancy, your doctor will likely support you staying off your medication so you can breastfeed. If your tumor caused symptoms during pregnancy and you need to restart medication immediately after delivery, you may not be able to breastfeed. This is an important conversation to have with your endocrinologist well before your due date.

Common questions in this guide

Will a prolactinoma stop me from getting pregnant?
A prolactinoma can cause temporary infertility by raising prolactin levels, which stops ovulation. However, treating the tumor with medication usually restores regular periods and fertility within a few months.
Are cabergoline and bromocriptine safe while trying to conceive?
Yes. Extensive research shows that dopamine agonists like cabergoline and bromocriptine are safe to take while trying to conceive and do not increase the risk of miscarriage or birth defects.
Should I stop taking my prolactinoma medication once I am pregnant?
Most women with small tumors (microprolactinomas) are advised to stop medication as soon as they have a positive pregnancy test. If you have a larger tumor, your doctor may recommend continuing the medication or monitoring you closely for symptoms.
Why won't my doctor check my prolactin levels during pregnancy?
Prolactin levels naturally skyrocket in all pregnant women to prepare for breastfeeding. Because blood tests cannot tell the difference between normal pregnancy prolactin and tumor prolactin, checking these levels is not useful during pregnancy.
Can I breastfeed if I have a prolactinoma?
Yes, breastfeeding is generally safe and does not cause the tumor to grow. However, if you need to restart your dopamine agonist medication right after delivery to treat the tumor, the medication will stop your breast milk production.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Should I get a baseline visual field eye exam before we start trying to conceive?
  2. 2.Which dopamine agonist do you recommend for my specific timeline and situation?
  3. 3.If I don't get pregnant after my periods have returned, at what point should I consult a reproductive endocrinologist?
  4. 4.How often will we monitor my symptoms or schedule visual field tests during my pregnancy?
  5. 5.What is our plan for managing the tumor if I decide to breastfeed?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (20)
  1. 1

    Interpretation of Serum Gonadotropin Levels in Hyperprolactinaemia.

    Abbara A, Clarke SA, Nesbitt A, et al.

    Neuroendocrinology 2018; (107(2)):105-113 doi:10.1159/000489264.

    PMID: 29660734
  2. 2

    Fertility and pregnancy in patients with prolactinoma.

    Stumpf MAM, Queiroz NL, Glezer A

    Best practice & research. Clinical endocrinology & metabolism 2026; 102081 doi:10.1016/j.beem.2026.102081.

    PMID: 41565497
  3. 3

    Hyperprolactinaemia in male infertility: Clinical case scenarios.

    Dabbous Z, Atkin SL

    Arab journal of urology 2018; (16(1)):44-52 doi:10.1016/j.aju.2017.10.002.

    PMID: 29713535
  4. 4

    The effect of bromocriptine treatment on sexual functioning and depressive symptoms in women with mild hyperprolactinemia.

    Krysiak R, Szkróbka W, Okopień B

    Pharmacological reports : PR 2018; (70(2)):227-232 doi:10.1016/j.pharep.2017.10.008.

    PMID: 29475005
  5. 5

    Is There a Role for Hormonal Therapy in Men with Oligoasthenoteratozoospermia (OAT)?

    Çayan S, Altay AB, Rambhatla A, et al.

    Journal of clinical medicine 2024; (14(1)) doi:10.3390/jcm14010185.

    PMID: 39797269
  6. 6

    Prolactinoma and pregnancy: From the wish of conception to lactation.

    Maiter D

    Annales d'endocrinologie 2016; (77(2)):128-34.

    PMID: 27130071
  7. 7

    Pregnancy and Tumor Outcomes in Women with Prolactinoma.

    Araujo B, Belo S, Carvalho D

    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2017; (125(10)):642-648 doi:10.1055/s-0043-112861.

    PMID: 28704852
  8. 8

    Outcomes of Patients with Macroprolactinoma Desiring Pregnancy: Follow-Up to 23 Years from a Single Center.

    Tanrikulu S, Yarman S

    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 2021; (53(6)):371-376 doi:10.1055/a-1468-4608.

    PMID: 33902136
  9. 9

    Prolactinomas in pregnancy: considerations before conception and during pregnancy.

    Glezer A, Bronstein MD

    Pituitary 2020; (23(1)):65-69 doi:10.1007/s11102-019-01010-5.

    PMID: 31792668
  10. 10

    Cabergoline Use and Pregnancy Outcomes: A Systematic Review.

    Otis AS, Brochet MS, Tremblay Z, et al.

    Birth defects research 2025; (117(3)):e2464 doi:10.1002/bdr2.2464.

    PMID: 40116053
  11. 11

    Managing Prolactinomas during Pregnancy.

    Almalki MH, Alzahrani S, Alshahrani F, et al.

    Frontiers in endocrinology 2015; (6()):85 doi:10.3389/fendo.2015.00085.

    PMID: 26074878
  12. 12

    How does pregnancy affect the patients with pituitary adenomas: a study on 113 pregnancies from Turkey.

    Karaca Z, Yarman S, Ozbas I, et al.

    Journal of endocrinological investigation 2018; (41(1)):129-141 doi:10.1007/s40618-017-0709-8.

    PMID: 28634705
  13. 13

    Disease Activity and Maternal-fetal Outcomes in Pregnant Women With Prolactinoma: A Systematic Review and Meta-analysis.

    Bandeira DB, Alves LS, Glezer A, et al.

    The Journal of clinical endocrinology and metabolism 2025; (110(4)):e1241-e1251 doi:10.1210/clinem/dgae821.

    PMID: 39584508
  14. 14

    Controversies in Breastfeeding.

    Davanzo R

    Frontiers in pediatrics 2018; (6()):278 doi:10.3389/fped.2018.00278.

    PMID: 30443539
  15. 15

    Neurosurgical anesthesia for a pregnant woman with macroprolactinoma: A case report.

    Xia Y, Ma X, Griffiths BB, Luo Y

    Medicine 2018; (97(37)):e12360 doi:10.1097/MD.0000000000012360.

    PMID: 30212994
  16. 16

    Management of hormone-secreting pituitary adenomas.

    Mehta GU, Lonser RR

    Neuro-oncology 2017; (19(6)):762-773 doi:10.1093/neuonc/now130.

    PMID: 27543627
  17. 17

    Prolactinoma and pregnancy - a series of cases including pituitary apoplexy.

    Galvão A, Gonçalves D, Moreira M, et al.

    Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 2017; (37(3)):284-287 doi:10.1080/01443615.2016.1233946.

    PMID: 27866462
  18. 18

    Prolactinoma Outcome After Pregnancy and Lactation: A Cohort Study.

    Laway BA, Baba MS, Bansiwal SK, Choh NA

    Indian journal of endocrinology and metabolism 2021; (25(6)):559-562 doi:10.4103/ijem.ijem_372_21.

    PMID: 35355922
  19. 19

    Does hyperprolactinemia treatment affect pregnancy and perinatal outcomes?

    Santos AC, Yela DA, Nakamura RM, et al.

    Revista da Associacao Medica Brasileira (1992) 2024; (70(10)):e20240634 doi:10.1590/1806-9282.20240634.

    PMID: 39536251
  20. 20

    An observational study of pregnancy and post-partum outcomes in women with prolactinoma treated with dopamine agonists.

    O'Sullivan SM, Farrant MT, Ogilvie CM, et al.

    The Australian & New Zealand journal of obstetrics & gynaecology 2020; (60(3)):405-411 doi:10.1111/ajo.13070.

    PMID: 31583693

This page provides general information about managing a prolactinoma during pregnancy for educational purposes only. Always consult your endocrinologist and obstetrician to create a personalized treatment and monitoring plan.

Get notified when new evidence is published on Prolactinoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.